Literature DB >> 10411300

Progenitor cells in the embryonic anterior pituitary abruptly and concurrently depress mitotic rate before progressing to terminal differentiation.

E Seuntjens1, C Denef.   

Abstract

The control of progenitor cell proliferation in concert with terminal differentiation during embryonic development is poorly understood. The present paper examines this issue in the different cell lineages of the fetal mouse pituitary. Mouse fetuses were pulse-exposed to 3H-thymidine (3H-T) on a single day between embryonic day (E) 10 and E16 (prior to the onset of hormone phenotype expression) and the 3H-T labeling index of each cell type determined 3 or 4 days later (E13-19), when hormone phenotypes were detectable. In the pars tuberalis primordium, TSHbeta appeared from E13. Of these cells 75.5% were labeled when 3H-T had been administered on E10. Label decreased to 40.8% when it had been incorporated on E11 and was negligible (4.2%) when it had been taken up on E12. In the pars distalis, ACTH appeared on E13, TSHbeta, and PRL on E14, LHbeta/FSHbeta on E15 and GH on E16. When examined on E16, all these cell types were labeled for 50-60% if 3H-T had been injected on E12, but this number dropped to about 15% when 3H-T had been given on E13. Only 5-10% of the hormonal cells had taken up label when E14, 15, and 16 were the days of 3H-T administration. The decline in overall labeling index (LI) within both parts of the pituitary was significantly smaller than that in the hormone expressing cells. It is concluded that an outspoken decline in proliferation of the cells destined to become hormone-expressing cell types occurs one to several days before these hormones come to expression. In the pars distalis, this decline occurs at a common time point i.e. between E12 and E13 for each cell type. Pars tuberalis and pars distalis TSHbeta cells show distinct 3H-T labeling profiles, suggesting distinct cell lineage sources for each.

Entities:  

Mesh:

Year:  1999        PMID: 10411300     DOI: 10.1016/s0303-7207(99)00028-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

2.  Birthdating studies reshape models for pituitary gland cell specification.

Authors:  Shannon W Davis; Amanda H Mortensen; Sally A Camper
Journal:  Dev Biol       Date:  2011-01-22       Impact factor: 3.582

3.  DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.

Authors:  Anat Ben-Shlomo; Nan Deng; Evelyn Ding; Masaaki Yamamoto; Adam Mamelak; Vera Chesnokova; Artak Labadzhyan; Shlomo Melmed
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  All Hormone-Producing Cell Types of the Pituitary Intermediate and Anterior Lobes Derive From Prop1-Expressing Progenitors.

Authors:  Shannon W Davis; Jessica L Keisler; María I Pérez-Millán; Vanessa Schade; Sally A Camper
Journal:  Endocrinology       Date:  2016-01-26       Impact factor: 4.736

5.  Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion.

Authors:  Yesenia Ríos; Shlomo Melmed; Shuo Lin; Ning-Ai Liu
Journal:  PLoS Genet       Date:  2011-01-13       Impact factor: 5.917

6.  SOX2 regulates the hypothalamic-pituitary axis at multiple levels.

Authors:  Sujatha A Jayakody; Cynthia L Andoniadou; Carles Gaston-Massuet; Massimo Signore; Anna Cariboni; Pierre M Bouloux; Paul Le Tissier; Larysa H Pevny; Mehul T Dattani; Juan P Martinez-Barbera
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.